Jheremy Sebastian Reyes

Jheremy Sebastian Reyes

Auto-generated profile, based on publicly available information

Jheremy Sebastian Reyes

Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh Medical Center, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2025 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
JRJheremy S. Reyes
Jheremy S. Reyes
VLVanshika N. Lohia
Vanshika N. Lohia
TATimoteo Almeida
Timoteo Almeida
ANAjay Niranjan
Ajay Niranjan
LLL. Dade Lunsford
L. Dade Lunsford
CHCostas G. Hadjipanayis
Costas G. Hadjipanayis

27 April 2026 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JRJheremy S. Reyes
Jheremy S. Reyes
TATimoteo Almeida
Timoteo Almeida
ABAlexandros Bouras
Alexandros Bouras
JMJoseph Mettenburg
Joseph Mettenburg
ANAjay Niranjan
Ajay Niranjan
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis

27 March 2026 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JRJheremy S. Reyes
Jheremy S. Reyes
DEDavid F. Estupiñan-Pepinosa
David F. Estupiñan-Pepinosa
SLSofia I. Leal-Giraldo
Sofia I. Leal-Giraldo
MCMaría F. Cordoba-Gallego
María F. Cordoba-Gallego
MSMaría P Silva-López
María P Silva-López
LNLuis M. Navarro-Ramirez
Luis M. Navarro-Ramirez

7 June 2026 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
JRJheremy S. Reyes
Jheremy S. Reyes
ABAlexandros Bouras
Alexandros Bouras
ANAjay Niranjan
Ajay Niranjan
LLL. Dade. Lunsford
L. Dade. Lunsford
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis

30 June 2024 in Revista Colombiana de Hematología y Oncología
Verified
Journal Article
Open access
PDF file
JBJheremy Sebastian Reyes Barreto
Jheremy Sebastian Reyes Barreto
CVCristian Sebastián Cabezas Varela
Cristian Sebastián Cabezas Varela
LJLeidy Viviana Girón Jurado
Leidy Viviana Girón Jurado
AEAna Margarita Baldión Elorza
Ana Margarita Baldión Elorza
Globally, breast cancer (BC) is the most common type of cancer, with 2.296.840 new cases in 2020 with almost 700.000 related deaths. Due to the high burden this represents, it is imperative to expand horizons to be able to find novel biomarkers and therapeutic targets that can be used to improve prognosis, treatment, and survival of breast cancer patients. In recent years, numerous studies have been conducted looking for the association between piRNAs (PIWI – interacting RNAs) and the development, pathogenesis, metastasis, and progression of different types of cancer, including BC. PiRNAs are small molecules (24-31 nucleotides) that interact with the PIWI-protein complex (PIWI-like proteins - HIWI/HILI in humans) performing regulatory functions by inducing transcriptional, post-transcriptional, translational, and post-translational epigenetic changes, which has been observed to contribute to cancer development through modifications in cell proliferation, transposon silencing, genome rearrangement, epigenetic regulation, protein regulation, and stem cell maintenance. In breast cancer, a strong association has been found between the expression of some piRNAs, PIWI-like proteins and tumor development. If a specific piRNA could be associated with a distinct type of cancer, it could then be used as an early biomarker which would allow for a better prognosis. Findings surrounding these molecular mechanisms could also spark interest in studies focusing on the modification of the expression of piRNAs in cancer cells. In this article, we intend to review in a straightforward manner the current information about piRNAs/PIWI-like proteins focusing on their expression in BC.

30 June 2024 in Revista Colombiana de Hematología y Oncología
Verified
Journal Article
Open access
PDF file
JBJheremy Sebastian Reyes Barreto
Jheremy Sebastian Reyes Barreto
LJLeidy Viviana Giron Jurado
Leidy Viviana Giron Jurado
MEMaria Paula Montoya Estrada
Maria Paula Montoya Estrada
IMIris Lorena Sánchez Moreno
Iris Lorena Sánchez Moreno
LMLaura Tatiana Picón Moncada
Laura Tatiana Picón Moncada
LFLibia Adriana Gaona Fernández
Libia Adriana Gaona Fernández
Multiple Myeloma (MM) is the second most common hematological malignancy and one of the 19 most frequent types of cancer. Its diagnosis is a challenge due to the low rate of disease recognition, and diagnosis delays lead to the characteristic end-organ damage of the disease. New approaches to tackle that diagnosis challenge are required. Emerging evidence shows that Piwi-interacting RNAs (piRNA) promote increased methylation in MM cells. In this analysis, we delve into the latest discoveries surrounding piRNA biogenesis and functions, offering fresh perspectives on the possible uses of piRNAs in detection and diagnosis in MM. piRNA-823 increases in MM cells and positively correlates with the disease stage. Its tumorigenic actions in MM relate to intercellular communication between MM and vein endothelial cells. These findings provide the necessary information to highlight the possible role of piRNA-823 as a biomarker for MM diagnosis.